Laboratory

Information provided in this section will be useful as physicians and patients.

On the spectrum of the research and interpretation of the results, you can consult with our experts of laboratory diagnosis.

Examination of the profiles is not compulsory and is conducted either by the administration of appropriate medical specialist, or - at the request of the patient;

Not possible to conduct studies on the entire profile, and selectively - by type of research (clinical, biochemical, serological, etc.).

Laboratory diagnosis and preparation for delivery of analyzes: 1.                    Blood studies to rent an empty stomach. 2.                   On the eve of the date of venous blood for research is necessary to eliminate fatty foods, alcohol, coffee. 3.                   Shortly before the fence material for PCR diagnosis of urogenital infections is necessary for 3 hours to refrain from urinating. Taking materials research: Mon. - Fri. 7:30 - 12:00 Sub. 8:00 - 11:00 Sun. - Output

In the medical center "Equator", the following laboratory tests:

A. General clinical:

1. Complete blood count with leukocyte differentiation, determination of ESR, platelet count.

2. Urinalysis, urine on Nechiporenko and Zimnitsky. 

B. Biochemical: more than 30 indicators (see table), as well as the determination of ionic composition (K ^{+, Na +, Cl -,} Ca ++ -ionizirovanny calcium) and reaction (pH) of the blood of glycosylated hemoglobin (HbA1c) - rapid test, blood sugar (glucose) in the venous blood (as part of the actual biochemical analysis), or separately (rapid test) - in capillary blood (from the finger).

Total protein	Total bilirubin
Albumen	Bilirubin direct
Urea	Alkaline phosphatase
Creatinine	Gammaglutamiltranspeptidaza (GGT)
Uric acid	Aspartate aminotransferase (AST)
Cholesterol general	Alanine aminotransferase (ALT)
Lipopoliproteidy high density lipoproteins (HDL)	Alpha-amylase
Lipopoliproteidy low density lipoprotein (LDL)	Lipase
Odds t-atherogenic	Creatine kinase (CK)
Apolipoprotein A-1 (APOA1)	Lactate dehydrogenase (LDH)
Apolipoprotein B (ApoB)	Calcium
Aspect. ApoB / APOA1	Phosphorus
Triglycerides	Magnesium
Ferritin	Iron
C-reactive protein (CRP)	Albuminuria
Antistreptolysin-O (ASL-O)	Alpha-amylase in urine
Rheumatoid factor (RF)	Glucose in the urine
Glucose

 

* - There is a possibility of the differentiated complex examination (6 options) depending on the diagnosis (existing or prospective), ultrasound findings, and others. - To get as much information about the functional state of the body in a single examination.

B. Determination of the blood coagulation system: PT / MHO. 

G. Analysis of ejaculate (semen)

D. cytological (definition of atypical cells in the biological material)

1. Gynecologic cervical smear.

2. aspirate from the cavity of the uterus.

3. The discharge from the nipple of the breast.

4. Fingerprint intrauterine device (IUD).

5. punctate of the posterior vaginal fornix.

E. Immunological and serological:

1. Monitoring of thyroid function *:

• TTG (TSH) - thyroid stimulating hormone;
• T4obsch. (TT4) - the total thyroxine;
• T4svob. (FT4) - a free thyroxine;
• Triglyceride (TG) - thyroglobulin;
• T3obsch. (TT3) - the total triiodothyronine;
• T3svob. (FT3) - free triiodothyronine;
• Al-TG (Ab-TG) - antibodies to thyroglobulin;
• TPO (Ab-TPO) - Antibodies to thyroid peroxidase.

2. Determination of the hormones (sex and metabolism)

• LH (LH) - luteinizing hormone;
• FSH (FSH) - follicle stimulating hormone;
• Cortisol;
• Progesterone;
• Prolactin;
• Testosterone general;
• Testosterone is advanced - for the determination;
• Estradiol (E2);
• 17-OH-progesterone;
• DHEA-S (DHEA-S) -degidroepiandrosteron sulfate;
• SSG - sex steroidsvyazyvayuschy globulin (SHBG, SHBG - binding globulin sex hormone);
• - PAPP-A - A plasma protein associated with pregnancy.

3. Determination of tumor markers (tumor markers) *:

• CEA (CEA, CEA) - carcinoembryonic (cancer) embryonic antigen;
• AFP (AFP) - AFP;
• S100;
• CA 125;
• CA 15-3;
• CA 19-9;
• CA 72-4;
• CA 242;
• NOT 4 in conjunction with CanAgCA125 - to determine the index ROMA (risk of ovarian cancer);
• FIGURE (CYFRA) 21;
• HCG (hCG) - human chorionic gonadotropin;
• TBG (TBG) - trophoblastic beta-1-glycoprotein;
• PSAobschy (PSA) - prostataspetsifichesky antigen;
• PSAsvobodny (FPSA) - free fraction of PSA
• SCC- antigen squamous cell carcinoma.

* - To increase the information content of this kind of research is possible to conduct a comprehensive survey for tumor markers in different organs and systems, which significantly increases the diagnostic value of analysis and detection of disease.

Adopt an integrated survey:

• thyroid;
• of the gastrointestinal tract (esophagus, stomach, colon, rectum);
• pancreas;
• liver and biliary system;
• easy;
• breast;
•  female genital organs (uterus, cervix, ovaries);
• prostate - prostate;
• eggs;
• skin (melanoma).

4. Early diagnosis and monitoring of pregnancy (maternal and fetal)

• HCG (hCG) - human chorionic gonadotropin;
• β-hCG free (β-hCGF) - a free beta subunit of human chorionic gonadotropin;
• AFP (AFP) - AFP;
• TBG (TBG) - trophoblastic beta-1-glycoprotein;
• PAPP-A - A plasma protein associated with pregnancy;
• PlGF- placental growth factor (risk of miscarriage);
• D-dimer (D-Dimer) - diagnosis of disseminated intravascular coagulation, leading to abortion and complications.

5. Diagnosis of urogenital chlamydia (Chlamydia trachomatis):

• determination of serum immunoglobulin (Ig) class A, M, GK C. trachomatis to determine the flow pattern of infection (acute, chronic infection, aggravation of the chronic infection, etc.).

6. Diagnostics ToRCH -group infections (toxoplasmosis, rubella, herpes 1 and 2tipov - HSV, CMV - CMV):

• Ig M antibodies to Toxoplasma gondii;
• The antibodies Ig G to Toxoplasma gondii;
• Ig M antibodies to the pathogen rubella;
• Ig G antibodies to the pathogen rubella;
• Ig M antibodies to CMV;
• Ig G antibodies to CMV;
• Ig G antibodies to CMV - avidity (to determine the activity of the infectious process);
• Ig M antibodies to HSV-1.2 types;
• Ig G antibodies to HSV-1.2 types;
• Ig G antibodies to HSV-1.2 types - avidity (to determine the activity of the infectious process);
• Ig G antibodies to HSV-2 type;
• Ig G antibodies to HSV-2 type - avidity (to determine the activity of the infectious process).

7. Diagnosis of infections transmitted when the tick bite (viral encephalitis - TBE, Lyme disease):

• The antibodies Ig M to the IRB;
• Ig G antibodies to the IRB;
• Lime - IgM;
• Lime - IgG.

8. Diagnosis and pneumoclamidiosis respiratory mycoplasmosis:

• determination of immunoglobulin class M, A, GK Chlamydophilapneumoniae, Mycoplasmapneumoniae with the establishment of the activity of the pathological process and control the effectiveness of treatment.

9. Diagnosing helminthiasis and infections caused by protozoa - determination of immunoglobulin GK agent:

• Giardiasis;
• Echinococcosis;
• Toxocariasis;
• Opisthorchiasis;
• Ascariasis.

10. Diagnosis of infectious mononucleosis (infection with Epstein-Barr virus) with active infection:

• M class antibodies to the capsid antigen of the pathogen (VEB - VCA- IgM);
• VEB EA - IgG;
• VEB NA - IgG.

11. Diagnostics helikobakterioza to establish a causal relationship between Helicobacter pylori infection and the presence of inflammatory processes in the organs of the gastrointestinal tract (gastritis, peptic ulcer and 12 duodenal ulcer), control cure:

• H.pylori-CagA- total antibody (M, A, G) to toxigenic strain of the pathogen;
• H.pylori- Ag- specific antigens of the pathogen in the feces (immunochromatographic rapid test).

12. Diagnosis of rotavirus and adenovirus infection:

• Rotavirus / Adenovirus- Kombi- certain antigens of pathogens in the stool.

13. Diagnosing the cause of allergic reactions (two-step method of evaluation of patients):

• Step 1 - Definition of total immunoglobulin E class to assess allergic status and a decision on the need for further examination;
• Stage 2 - determination of the concentration of immunoglobulin E allergospetsificheskih to complexes of allergens (20 pcs. In one formulation) on standard allergopanelyam (there are 11 variants) or single allergens (there are 30 names).

14. Determination of cardiac markers for the diagnosis of heart muscle damage (myocardial infarction), congestive heart failure markers (including prognosis after treatment), thromboembolism:

• Myoglobin,
• Creatine kinase-MB,
• Troponin I,
• Sodium (di) peptide-uretichesky BNP,
• D-dimer.

15. Diagnosis of antiphospholipid syndrome:

• Anticardiolipin antibody classes M and G (ACA-IgM, ACA-IgG),
• Antiphospholipid antibody classes M and G (APLA-IgM, APLA-IgG),
• Antibodies classes M and G beta-2-glycoprotein (b2GP-IgM, b2GP-IgG).

16. Diagnosis of systemic connective tissue diseases (rheumatoid arthritis, systemic lupus erythematosus - SLE):

• Screening of antinuclear antibodies (ANA-IgG),
• Antibodies to cyclic citrullinated peptide (anti-CCP-IgG),
• Antibodies to double-stranded DNA (anti-dsDNA-IgG).

J. Definition of infectious diseases, sexually transmitted infections, a high cancer risk and others. Method of molecular diagnostics (polymerase chain reaction - PCR).

1. Sexually transmitted infections (STIs):

• Chlamydia (C.trachomatis) - scraping;
• Trichomonas (Tr.vaginalis) - scraping;
• Ureaplasmas (U.urealyticum / U.parvum) - scraping;
• Mycoplasma (M.genitalium) - scraping;
• Mycoplasma (M.hominis) - scraping;
• Gonorrhoea (Neisseria gonorrhoeae) - scraping;
• Candidiasis (Candida albicans) - scraping;
• Bacterial vaginosis (Gardnerella vaginalis) - scraping;
• Cytomegalovirus (CMV) infection - scraping;
• Herpes (HSV-1.2 type) - scraping;
• Multipraym- FL (C.trachomatis, Ureaplasma spp, Mycoplasma genitalium
• The complex number 1: Multipraym- FL (C.trachomatis, Ureaplasma spp, Mycoplasma genitalium) + Mycoplasma hominis (Mycoplasma hominis) scraping);
• The complex number 2: Multipraym- FL (C.trachomatis, Ureaplasma spp, Mycoplasma genitalium) + Neisseria gonorrhea (Neisseria gonorrhoeae) scraping);
• The complex number 3: Multipraym- FL (C.trachomatis, Ureaplasma spp, Mycoplasma genitalium) + Trihomonas vaginalis (Trichomonas vaginalis) scraping);
• Research biocenosis genital tract in women (Femoflor-16).

2. Infectious and parasitic diseases:

• Cytomegalovirus (CMV) infection - blood
•  Herpes (HSV-types 1.2) - blood
• Infectious mononucleosis (Epstein-Barr virus - EBV) - blood;
• The system Lyme borreliosis (Lyme disease) - Blood (early diagnosis of infection).

3. Factors high cancer risk (cervical cancer):

• Human papillomavirus (HPV) types 16 and 18 - scraping (the probability of detection - up to 72%),
• Human papillomavirus (HPV WRC screen - analysis of 11 HPV types 16, 18,31, 33, 35, 39, 45, 52, 58, 59, 67 tipov- scraping (the probability of detection - 97%),
• Human papillomavirus (HPV genotype WRC - analysis of 14 types of HPV quantifying each of pathogens (viral load) - evaluation of the risk of the disease, an objective monitoring of the effectiveness of the treatment.

4. smear study gynecological and urological strokes.

I. Identification of the causative agents of urogenital system:

- Urogenital mycoplasmosis (Mycoplasmahominis, Ureaplasmaurealyticum):

= With the definition of clinically relevant concentrations of microorganisms and antibiotic susceptibility - antibiotikogrammy (IST test 2);

= Control of cure (test LYO 2);

- Determination of microorganisms, leading to the appearance of inflammatory diseases of the urinary tract - Mycoplasmahominis, Ureaplasmaurealyticum (with antibiotikogrammy) +10 representatives of pathogenic and conditionally pathogenic microorganisms (test AFGenitalSystem);

- Determination of microorganisms that give rise to inflammatory diseases of the urinary tract in the presence of urinalysis substantial number of bacteria - species, quantity and sensitivity to 14 antibiotics (test Urine System Plus, when the result within 24 hours).

A list of profiles survey

(full list of studies is available from the registry at tel. 160). *

For convenience and to ensure the best possible service seeking the services of laboratory diagnosis for one visiting the medical center of the above studies is part of the so-called profiles surveys problematic for patients fronts. It allows you to optimize the diagnostic process, helping clinicians to quickly and accurately correct diagnosis, to conduct objective control of the effectiveness of treatment is prescribed.

1. The primary biochemical examination - to control the basic biochemical parameters.

Objective: an overall assessment of the state of the major organs and body systems to identify possible irregularities in their functioning.

2. Adetailed biochemical examination + general clinical research - includes an extended range of biochemical studies, common blood and urine tests,

Objective: To assess the status of nearly all organs and body systems, the definition of the location and severity of pathological processes for the subsequent choice of doctors tactics monitoring, treatment and monitoring of treatment.

3. The risk of developing cardiovascular disease (atherosclerosis, metabolic syndrome, coronary heart disease) - to establish the causes that contribute to the emergence of this disease.

4. Suspected myocardial infarction, acute coronary syndrome - in case of pain in the heart.

5. Heart failure (shortness of breath, fluid retention in the body, the risk of complications and prognosis).

6. Hypertensive - to determine the main causes of high blood pressure associated with the condition of the blood vessels, kidneys, carbohydrate and ion exchange, the need for correction of nutrition.

7. Liver function tests - for the initial evaluation of the functional state of the liver in order to determine the need for further examination of the body.

8. Monitoring of liver function - detailed - complete examination hepatobiliary (liver, bile ducts), including possible contamination with viral hepatitis B and C, establishing the need for correction of nutrition.

9. Kidney disease - to determine the functional state of the kidneys and urinary tract, diagnostics possible violations need to adjust the power and control of the effectiveness of the treatment.

10. Joint pain-1 - to determine possible causes of diseases of joints and / or periarticular tissues, including infectious and autoimmune nature (reactive, rheumatoid arthritis and so forth.).

10A. Pain in the joints 2 - Rheumatic - to establish the causes of inflammatory diseases of the joints and periarticular tissues.

11. Pancreatic - to determine the functional state of the pancreas and the related possibility of carbohydrate, protein and fat metabolism by determining the activity of the corresponding enzymes.

12. Liver + pancreatic - to determine the state of the liver and pancreas, as well as related metabolic disorders - fat, protein, carbohydrates, establishing the fact of infection with viral hepatitis B and C.

13. Lipid metabolism - to determine the main parameters of lipid metabolism, its influence on the occurrence of violations and the risk of heart and vascular diseases (arteriosclerosis, myocardial infarction, stroke).

14. Immunological profile - for the initial evaluation of the immune system, the definition of a possible sensitization, diagnose latent chronic inflammatory processes.

15. Overweight - to establish a basic metabolic (metabolism) and hormonal causes of obesity, determining the tactics of the further treatment, the need for correction of nutrition.

16. Gastrointestinal tract - to establish digestive disorders associated with infection by the microorganism Helicobacter pylori), determining the need for treatment.

17. Gastrointestinal + pancreas - to establish digestive disorders associated with infection by the microorganism Helicobacter pylori, abnormalities of carbohydrate, protein and fat metabolism.

18. The control in diabetes mellitus - to determine the functional state of organs and systems at diagnosis of diabetes, control of the treatment, diagnosis, possible complications of the underlying disease.

19. Bone - to establish the metabolic (metabolism) the reasons for the increased bone fragility and monitoring the effectiveness of treatment, including power adjustments.

20. Anemic - to establish the reasons for the low concentration of hemoglobin (anemia), inadequate functioning of the hematopoietic system, monitoring the effectiveness of the treatment, including power adjustments.

21. Cancer - in addition to a comprehensive survey for the presence of tumor markers and / or to control the effect on the organs and systems of treatments at diagnosis cancer.

22. Pregnant (1st term) - to monitor the condition of the mother and fetus.

23. Pregnant women (from 14 th to 20 th week) - to monitor the condition of the mother and fetus and diagnose birth defects.

24. pregnancy (3rd trimester) - to monitor maternal and fetal condition, predicting possible complications in childbirth.

25. Preoperative - to monitor the state of health prior to the intended surgery.

26. Expectant mother - women of childbearing age for 2-3 months before planned pregnancy, especially - if in the past to terminate the pregnancy.

27. Female hormones (1st phase of the cycle) - to monitor the hormonal status in the follicular and ovulatory phases of the menstrual cycle.

28. Female hormones (2nd phase of the cycle) - to monitor the hormonal status in the luteal phase of the menstrual cycle.

29. The male hormone - to control the hormonal status in men.

30. Worms - clinical, biochemical and immunological tests to determine whether infection with worms and related pathological changes in the internal organs, the immune system, for monitoring the effectiveness of treatment.

* Note:

- A complete description of the composition of the profiles stored in the registry of the medical center;

- Inspection of the profiles is not compulsory and is conducted either by the administration of appropriate medical specialist, or - at the request of the patient;

- Possibly carrying out the studies on the entire profile, and selectively - by type of research (clinical, biochemical, serological, etc.).

In addition, the corresponding profiles are available for research:

- Control of the functional state of the thyroid gland (including when it is detected nodules by ultrasound);

- The diagnosis of allergic reactions to the establishment of specific allergens;

- The diagnosis and monitoring of treatment of malignant tumors.

 

The diversity of research helps determine the state of health of the person and its dynamics, to identify the different types of infectious agents, hormonal and functional characteristics of most of his organs and systems, etc. The main objective of this type of diagnosis is to identify or confirm the presence of disease, which can not be unequivocally confirm or deny the organoleptic research methods.

In our laboratory conducted as regular studies: clinical, biochemical, determination of thyroid hormones, sex and metabolism, and specific diagnosis of a range of infectious diseases, the determination of markers of tumor growth (tumor markers), control of allergic reactions to the definition of a causal connection with specific allergens.

The PCR laboratory diagnosis is performed to search for specific pathogens at the molecular genetic level.

Laboratory medical center "Equator":

• modern diagnostic equipment;
• original reagents;
• PCR own laboratory diagnostics;
• highly qualified specialists;
• advanced testing of the material;
• high information data;
• a wide range of ongoing research;
•  all analyzes are done on-site;
• research costs are inclusive of accessibility for residents of Lida and Lida region.

Integrated Laboratory Diagnostics - a pledge of competent treatment!